Literature DB >> 22184734

The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer.

Valerie Beral1, Maggie Alexander, Stephen Duffy, Ian O Ellis, Rosalind Given-Wilson, Lars Holmberg, Sue M Moss, Amanda Ramirez, Malcolm W R Reed, Caroline Rubin, Patsy Whelehan, Robin Wilson, Kenneth C Young.   

Abstract

The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer depends strongly on several factors, including the age at which regular screening starts, the period over which it continues, and the duration of follow-up after screening. Furthermore, more women would need to be INVITED for screening than would need to be SCREENED to prevent one death, since not all women invited attend for screening or are screened regularly. Failure to consider these important factors accounts for many of the major discrepancies between different published estimates. The randomised evidence indicates that, in high income countries, around one breast cancer death would be prevented in the long term for every 400 women aged 50-70 years regularly screened over a ten-year period.

Entities:  

Mesh:

Year:  2011        PMID: 22184734      PMCID: PMC3266234          DOI: 10.1258/jms.2011.011134

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  6 in total

1.  Screening for breast cancer in England: past and future.

Authors: 
Journal:  J Med Screen       Date:  2006       Impact factor: 2.136

2.  Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.

Authors:  László Tabár; Bedrich Vitak; Tony Hsiu-Hsi Chen; Amy Ming-Fang Yen; Anders Cohen; Tibor Tot; Sherry Yueh-Hsia Chiu; Sam Li-Sheng Chen; Jean Ching-Yuan Fann; Johan Rosell; Helena Fohlin; Robert A Smith; Stephen W Duffy
Journal:  Radiology       Date:  2011-06-28       Impact factor: 11.105

Review 3.  Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Kari Tyne; Arpana Naik; Christina Bougatsos; Benjamin K Chan; Linda Humphrey
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

Review 4.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Margrethe Nielsen
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

5.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321

Review 6.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

  6 in total
  10 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

2.  An Enhanced Shared Decision Making Model to Address Willingness and Ability to Undergo Lung Cancer Screening and Follow-Up Treatment in Minority Underserved Populations.

Authors:  Cherie P Erkmen; Mark Mitchell; Simran Randhawa; Shelby Sferra; Rachel Kim; Verdi DiSesa; Larry R Kaiser; Grace X Ma
Journal:  J Community Health       Date:  2018-02

3.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

Review 4.  Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention.

Authors:  Silvia Franceschi; Christopher P Wild
Journal:  Mol Oncol       Date:  2012-11-17       Impact factor: 6.603

5.  Why the time is right to tackle breast and cervical cancer in low-resource settings.

Authors:  Vivien Davis Tsu; Jose Jeronimo; Benjamin O Anderson
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

6.  A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.

Authors:  Anssi Auvinen; Antti Rannikko; Kimmo Taari; Paula Kujala; Tuomas Mirtti; Anu Kenttämies; Irina Rinta-Kiikka; Terho Lehtimäki; Niku Oksala; Kim Pettersson; Teuvo L Tammela
Journal:  Eur J Epidemiol       Date:  2017-07-31       Impact factor: 8.082

7.  Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Authors:  N B Gunsoy; M Garcia-Closas; S M Moss
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

8.  National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017.

Authors:  Cristina Bosetti; Eugenio Traini; Tahiya Alam; Christine A Allen; Giulia Carreras; Kelly Compton; Christina Fitzmaurice; Lisa M Force; Silvano Gallus; Giuseppe Gorini; James D Harvey; Jonathan M Kocarnik; Carlo La Vecchia; Alessandra Lugo; Mohsen Naghavi; Alyssa Pennini; Cristiano Piccinelli; Luca Ronfani; Rixing Xu; Lorenzo Monasta
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

9.  Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study.

Authors:  Søren R Christiansen; Philippe Autier; Henrik Støvring
Journal:  Eur J Public Health       Date:  2022-08-01       Impact factor: 4.424

10.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.